HT

Hukami Tulsi

Director Director DIN 02362627
DIN 02362627 First appointment Oct 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2008
Shareholding value Locked Premium profile

About Hukami Tulsi

Data last updated:

Hukami Tulsi has 17 years in corporate governance. Formerly with 1 company, such as Jai Mangla Medicines Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02362627
Primary Designation Director
First Appointment 24 Oct 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Jai Mangla Medicines Private Limited U24232RJ2008PTC027630
Director24 Oct 20082008Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jai Mangla Medicines Private Limited
Premium access

Shareholding and investment profile for Hukami Tulsi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hukami Tulsi

Hukami Tulsi has 17 years in corporate governance. Formerly with 1 company, such as Jai Mangla Medicines Private Limited. Engaged in General Business. Contributes to corporate operations.

Hukami Tulsi is associated with 0 companies as a director.

Hukami Tulsi has expertise in General Business.

Hukami Tulsi has 17 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available